Jon‐Vidar Gaustad

44 papers receiving 802 citations

Peers

Jon‐Vidar Gaustad
Comparison fields: 5 of 73
  • Radiology, Nuclear Medicine and Imaging 379
  • Cancer Research 244
  • Oncology 196
  • Molecular Biology 192
  • Biomedical Engineering 172
Replace Trude G. Simonsen with:
Trude G. Simonsen Norway
Melania Pintilie Canada
W. Weikel Germany
Wolf‐Dietrich Beecken Germany
Klaus J. Weber Germany
Hans Peters Netherlands
Anton G.T. Terwisscha van Scheltinga Netherlands
Shinya Neri Japan
Jeanne Thomassin‐Piana France
Joseph F. Montebello United States
Jon‐Vidar Gaustad relative to Trude G. Simonsen Norway Trude G. Simonsen's profile →
Citations per field
00.5×1.5×
Trude G. Simonsen · 1×
Citations per year

Countries citing papers authored by Jon‐Vidar Gaustad

Since Specialization
Citations

This map shows the geographic impact of Jon‐Vidar Gaustad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon‐Vidar Gaustad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon‐Vidar Gaustad more than expected).

Fields of papers citing papers by Jon‐Vidar Gaustad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon‐Vidar Gaustad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon‐Vidar Gaustad. The network helps show where Jon‐Vidar Gaustad may publish in the future.

Co-authorship network of co-authors of Jon‐Vidar Gaustad

This figure shows the co-authorship network connecting the top 25 collaborators of Jon‐Vidar Gaustad. A scholar is included among the top collaborators of Jon‐Vidar Gaustad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon‐Vidar Gaustad. Jon‐Vidar Gaustad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 10
3 10
4 2
5 28
6 4
7 21
8 3
9 12
10 37
11 25
12 16
13 7
14 28
15 2
16 31
17 9
18 35
19 22
20 36

About Jon‐Vidar Gaustad

Jon‐Vidar Gaustad is a scholar working on Cancer Research, Radiology, Nuclear Medicine and Imaging and Oncology, having authored 44 papers that have together received 809 indexed citations. Recurring topics across this work include MRI in cancer diagnosis (19 papers), Cancer, Hypoxia, and Metabolism (18 papers) and Angiogenesis and VEGF in Cancer (18 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (379 citations), Cancer Research (244 citations) and Obstetrics and Gynecology (88 citations). Jon‐Vidar Gaustad has collaborated with scholars based in Norway. Frequent co-authors include Einar K. Rofstad, Trude G. Simonsen, T Egeland, Catherine S. Wegner, Berit Mathiesen, Anette Hauge, Kristine Gulliksrud, Kanthi Galappathi, Christine Ellingsen and Kjetil Gundro Brurberg. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Magnetic Resonance in Medicine and Journal of Theoretical Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026